Surgery for melanoma metastatic to the gastrointestinal tract

Annals of Surgical Oncology

Volumn 6, Issue 4, 1999, Pages 336-344

  Agrawal, Shefali ^a   Yao, Tzy Jyun ^b   Coit, Daniel G ^b  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Gastrointestinal tract; Melanoma; Surgery

Indexed keywords

LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MORBIDITY; PALLIATIVE THERAPY; PROGNOSIS; RECURRENT DISEASE; SURGICAL MORTALITY; SYMPTOMATOLOGY;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0033019987     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-999-0336-5     Document Type: Article

References (30)

1. de la Monte SM, Moore GW, Hutchins GM. Patterned distribution of metastases from malignant melanoma in humans. Cancer Res 1983;43:3427-33.
2. Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 1978;135:807-10.
3. Reintgen DS, Thompson W, Garbutt J, Seigler HF. Radiologic, endoscopic and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery 1984;95:635-9.
4. Ihde JK, Coit DG. Melanoma metastatic to stomach, small bowel or colon. Am J Surg 1991;162:208-11.
5. Caputy GG, Donohue JH, Goellner JR, Weaver AL. Metastatic melanoma of the gastrointestinal tract. Arch Surg 1991;126:1353-8.
6. Khadra MH, Thompson JF, Milton GW, McCarthy WH. The justification of surgical treatment of metastatic melanoma of the gastrointestinal tract. Surg Gynecol Obstet 1990;171:413-6.
7. Ricaniadis N, Konstadoulakis MM, Walsh D, Karakousis CP. Gastrointestinal metastases from malignant melanoma. Surg Oncol 1995;4:105-10.
8. Ollila DW, Essner R, Wanek LA, Morton DL. Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg 1996;131:975-80.
9. Branum GD, Seigler HF. Surgical intervention in the management of intestinal metastases from malignant melanoma. Am J Surg 1991;162:428-31.
10. Jorge E, Harvey HA, Simmonds MA, Lipton A, Joehl RJ. Symptomatic malignant melanoma of the gastrointestinal tract: operative treatment and survival. Ann Surg 1986;199:328-31.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
12. Peto R, Pike MC, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observations of each patient, II: analysis and examples. Br J Cancer 1977;35:1-39.
13. Hochberg Y, Hamhane AC. Introduction. In: Multiple comparison procedures. New York: John Wiley & Sons, 1987:1-16.
14. McDermott VG, Low VHS, Keogan MT, Lawrence JAL, Paulson EK. Malignant melanoma metastatic to the gastrointestinal tract. Am J Radiol 1996;166:809-13.
15. Klaase JM, Kroon BBR. Surgery for melanoma metastatic to the gastrointestinal tract. Br J Surg 1990;77:60-1.
16. Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 1995; 181:193-201.
17. Karakousis CP, Velez A, Driscoll DL, Takita H. Metastatectomy in malignant melanoma. Surgery 1994;115:295-302.
18. Hena MA, Emrich LJ, Nambisan RN, Karakousis CP. Effect of surgical treatment on Stage IV melanoma. Am J Surg 1987;153: 270-5.
19. Overett TK, Shiu MH. Surgical treatment of distant metastatic melanoma. Cancer 1985;56:1222-30.
20. Popat U, Przepiork D, Champlin R, et al. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: Mediastinal localization predicts for a favorable outcome. J Clin Oncol 1998;16:63-9.
21. International Germ Cell Cancer Collaborative Group. International germ cell consensus classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 15:594-603.
22. Aparicio J, Munarriz B, Pastor M, et al. Long-term follow-up and prognostic factors in Ewing's sarcoma. A multivariate analysis of 116 patients from a single institution. Oncology 1998;55:20-6.
23. Ferrari S, Bacci G, Picci P, et al. Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol 1997;8:765-71.
24. Maestu I, Pastor M, Gomez-Codina J, et al. Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices in 341 patients. Ann Oncol 1997;8:547-53.
25. Herndon JE II, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 1998;113:723-31.
26. Furuya Y, Akimoto S, Akakura K, Igarashi T, Murakami S, Shimazaki J, Ito H. Response of prostate-specific antigen after androgen withdrawal and prognosis in men with metastatic prostate cancer. Urol Int 1998;60:28-32.
27. Liaw CC, Wang CH, Huang JS, Kiu MC, Chen JS, Chang HK. Serum lactate dehydrogenase level in patients with nasopharyngeal carcinoma. Acta Oncol 1997;36:159-64.
28. Sirott MN, Bajorin DF, Wong GYC, Tao Y, Chapman PB, Templeton MA, Houghton AN. Prognostic factors in patients with metastatic malignant melanoma. Cancer 1993;72:3091-8.
29. Eton O, Legha SS, Moon TE, et al. Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol 1998;16:1103-11.
30. Keilholz U, Scheibenbogen C, Sommer M, Pritsch M, Geuke AM. Prognostic factors for response and survival in patients with metastatic melanoma receiving immunotherapy. Melanoma Res 1996; 6:173-8.